Trial Profile
Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Open-label Trial-
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Duodenal ulcer; Gastric ulcer; NSAID-induced ulcer
- Focus Adverse reactions
- Acronyms Planetarium
- Sponsors Eisai Co Ltd
- 06 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.